DopamineReceptors, Dopamine D2Parkinson DiseaseReceptors, Dopamine D1Dopamine AgonistsDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D3BrassicaMolybdenumDopamine Plasma Membrane Transport ProteinsReceptors, NeuropeptideDopamine AgentsReceptors, G-Protein-CoupledReceptors, GABA-ATriamcinolone AcetonideNeuropeptidesGTP-Binding Protein alpha Subunits, Gi-GoReceptors, Dopamine D5Dopamine Uptake Inhibitorsalpha-SynucleinCytosolCorpus StriatumAntiparkinson AgentsLevodopaPollenDopamine beta-HydroxylaseParkinsonian DisordersSubstantia NigraCentrifugation, Density GradientDopaminergic NeuronsParkinson Disease, SecondaryCell LineOxidopamineQuinpiroleBenzazepinesRacloprideTyrosine 3-MonooxygenaseApomorphineNeostriatumNucleus AccumbensMolecular Sequence DataMesencephalon1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuronsSulpiridePutamenCell NucleusHaloperidolSalicylamidesGlucosylceramidaseCocaineBrainLewy BodiesAmphetamineHomovanillic AcidMPTP PoisoningDeep Brain StimulationRats, Sprague-DawleyTropanesDopamine and cAMP-Regulated Phosphoprotein 32MicrodialysisSpiperoneCaudate NucleusVentral Tegmental AreaDihydroxyphenylalaninePergolideMultiple System AtrophyCarbidopaVesicular Monoamine Transport ProteinsErgolinesSubthalamic NucleusMotor ActivityBehavior, Animalalpha-MethyltyrosineBasal GangliaDomperidoneNeurodegenerative DiseasesLewy Body DiseaseNomifensineFlupenthixolGait Disorders, NeurologicNerve Tissue ProteinsDyskinesia, Drug-InducedSupranuclear Palsy, ProgressiveDose-Response Relationship, DrugBromocriptineRewardPostural BalancePositron-Emission TomographyAdrenergic AgentsGlobus PallidusMethamphetamineBiogenic MonoaminesButaclamolAnalysis of VarianceSerotoninBenzothiazolesNerve DegenerationPedunculopontine Tegmental Nucleus